BioLineRx Ltd. Cost Of Sales
BioLineRx Ltd. (BLRX) reported Cost Of Sales of $230.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-03-23
- BioLineRx Ltd. cost of sales for the quarter ending 2025-06-30 was $72.00K, a 91.97% decline year-over-year.
- BioLineRx Ltd. cost of sales for the quarter ending 2024-06-30 was $897.00K.
- BioLineRx Ltd. cost of sales for the quarter ending 2023-06-30 was $0.00.
| Period end | Cost Of Sales 3 month | Cost Of Sales 6 month | Cost Of Sales 12 month |
|---|---|---|---|
| 2025-12-31 | $230.00K 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $72.00K 6-K · filed 2025-08-14 | $106.00K 6-K · filed 2025-08-14 | |
| 2024-12-31 | $9.26M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $897.00K 6-K · filed 2025-08-14 | $2.35M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $3.69M 20-F · filed 2026-03-23 | ||
| 2023-06-30 | $0.00 6-K · filed 2024-08-15 | $0.00 6-K · filed 2024-08-15 | |
| 2022-12-31 | $0.00 20-F · filed 2025-03-31 | ||
| 2021-12-31 | $0.00 20-F · filed 2024-03-26 |